Meta analysis of efficacy and safety of Bailemian therapy for insomnia

夏娟,陈其文,邓青龙,唐富荣,杨忍忍,余金明,王继伟
DOI: https://doi.org/10.3969/j.issn.1004-1648.2017.04.002
2017-01-01
Journal of Clinical Neurology
Abstract:Objective To evaluate the relationship among the efficacy, safety and the course of disease of Bailemian therapy for insomnia.Methods Literatures which before Dec, 2016 on Bailemian therapy for insomnia were retrieved by China journal full-text database (CNKI), Wanfang database, Chinese outstanding master`s/doctoral dissertation database, VIP science and technology periodical database, Cochrane library, Pubmed, EMBASE and Chinese academic conference papers, and then evaluated by Jadad scale, analyzed with Stata 14 software.Results Twenty articles including 2235 patients (1284 cases in Bailemian group, 951 cases in control group) were included.Total effective rate of insomnia in Bailemian group was significantly increased than that in control group (RR=1.20, 95%CI: 1.10-1.31).Total effective rate of insomnia in Bailemian group was significantly increased than that in western medicine subgroup (RR=1.24, 95%CI: 1.07-1.44) and Chinese medicine (TCM) subgroup (RR=1.13, 95%CI: 1.03-1.23).Reducing Pittsburgh sleep quality index (PSQI) score in Bailemian group was better than that in control group [standardized mean difference (SMD)=-0.53, 95%CI:-0.81——0.26].With the prolonged theraputic period (2nd, 3th and 4th weeks), the advantage of reducing PSQI score in Bailemian group was highlight gradually than western medicine subgroup (SMD2=-0.50, 95%CI: 0.83——0.16;SMD3=-0.60, 95%CI:-0.97——0.24;SMD4=-1.67, 95%CI:-0.63——0.05).The incidence of adverse reaction in Bailemian group was significantly increased than that in control group (RR=0.25, 95%CI: 0.16-0.38).The incidence of adverse reaction in Bailemian group was significantly increased than that in western medicine subgroup (RR=0.23, 95%CI: 0.15-0.36).With the prolonged theraputic period (2nd, 3th 4th and 8th weeks), the incidence of adverse reaction in Bailemian group was highlight gradually than western medicine subgroup(RR2=0.45, 95%CI:0.22-0.92;RR3=0.23, 95%CI:0.04-1.33;RR4=0.16, 95%CI:0.08-0.33;RR8=0.19, 95%CI: 0.06-0.59).Conclusions Total effective rate and reducing PSQI score of Bailemian therapy forinsomnia are superior to other TCM and western medicine, and it is safety.It might be worth further popularizing in clinical use.Further studies are still needed to vertify whether the longer the courses are, the more significant of the efficacy on Bailemian therapy for insomnia than other drugs.
What problem does this paper attempt to address?